SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines

Abstract excerpt

Background/Aim: Prostate cancer (PCa) is the most commonly diagnosed genital cancer in men globally. Among patients who develop advanced PCa, 80% are affected by bone metastasis, with a sharp drop in survival rate. Despite efforts, the details of mechanisms of metastasis of PCa remain unclear. SIRT5, an NAD+-dependent deacylase, is hypothesized to be a crucial regulator of various cancers. The role of SIRT5 in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Endoplasmic Reticulum Stress and Disease
• Share to PARP inhibition in cancer therapy
• Share to Sirtuins and Resveratrol in Medicine